Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On March 8, 2018, the Compensation Committee of the board of directors (the “Committee”) of Ekso Bionics Holdings, Inc. (the “Company”) approved the payment of bonuses to the Company’s employees, including the payment of discretionary bonuses to the Company’s named executive officers to the terms of the Company’s 2017 short term incentive plan (the “STIP”), for their performance during the fiscal year ended December 31, 2017.

As permitted by the STIP, the Committee apportioned the bonus payments to the named executive officers of the Company between cash payments and immediately-vested stock grants under the Company’s Amended and Restated 2014 Stock Incentive Plan (the “2014 Plan”), except with respect to Thomas Looby, the Company’s former President and Chief Executive Officer, who, as previously announced, received a lump sum cash bonus payment to the terms of his separation agreement. Accordingly, on March 22, 2018, the following immediately-vested stock grants were issued to the named executive officers listed below under the 2014 Plan:

All compensation for the named executive officers for the fiscal year ended December 31, 2017, including the compensation disclosed above, will be reported by the Company in the Summary Compensation Table in the Company’s proxy statement relating to the Company’s 2018 Annual Meeting of Shareholders (“Proxy Statement”), to be filed with the Securities and Exchange Commission (“SEC”) no later than 120 days after December 31, 2017.

As of today, the Company will use its Twitter account (@EksoBionics) from time to time to post material information about the Company and its business, affairs, operations and financial conditions. Shareholders are advised to follow the Company’s Twitter account.